1. Epidemiology and Global Health
  2. Medicine

Mathematical modeling of the West Africa Ebola epidemic

  1. Jean-Paul Chretien  Is a corresponding author
  2. Steven Riley
  3. Dylan B George
  1. Division of Integrated Biosurveillance, Armed Forces Health Surveillance Center, United States
  2. School of Public Health, Imperial College London, United Kingdom
  3. Biomedical Advanced Research and Development Authority, United States
https://doi.org/10.7554/eLife.09186
Share this article
Cite this article
  1. Jean-Paul Chretien
  2. Steven Riley
  3. Dylan B George
(2015)
Mathematical modeling of the West Africa Ebola epidemic
eLife 4:e09186.
https://doi.org/10.7554/eLife.09186
  2. Download BibTeX
  3. Download .RIS

Abstract

As of November 2015, the Ebola virus disease (EVD) epidemic that began in West Africa in late 2013 is waning. The human toll includes more than 28,000 EVD cases and 11,000 deaths in Guinea, Liberia, and Sierra Leone, the most heavily-affected countries. We reviewed 66 mathematical modeling studies of the EVD epidemic published in the peer-reviewed literature to assess the key uncertainties models addressed, data used for modeling, public sharing of data and results, and model performance. Based on the review, we suggest steps to improve the use of modeling in future public health emergencies.

https://doi.org/10.7554/eLife.09186.001

eLife digest

The outbreak of Ebola that started in West Africa in late 2013 has caused at least 28,000 illnesses and 11,000 deaths. As the outbreak progressed, global and local public health authorities scrambled to contain the spread of the disease by isolating those who were ill, putting in place infection control processes in health care settings, and encouraging the public to take steps to prevent the spread of the illness in the community. It took a massive investment of resources and personnel from many countries to eventually bring the outbreak under control.

To determine where to allocate people and resources during the outbreak, public health authorities often turned to mathematical models created by scientists to predict the course of the outbreak and identify interventions that could be effective. Many groups of scientists created models of the epidemic using publically available data or data they obtained from government officials or field studies. In some instances, the models yielded valuable insights. But with various groups using different methods and data, the models didn’t always agree on what would happen next or how best to contain the epidemic.

Now, Chretien et al. provide an overview of Ebola mathematical modeling during the epidemic and suggest how future efforts may be improved. The overview included 66 published studies about Ebola outbreak models. Although most forecasts predicted many more cases than actually occurred, some modeling approaches produced more accurate predictions, and several models yielded valuable insights. For example, one study found that focusing efforts on isolating patients with the most severe cases of Ebola would help end the epidemic by substantially reducing the number of new infections. Another study used real-time airline data to predict which traveler screening strategies would be most efficient at preventing international spread of Ebola. Furthermore, studies that obtained genomic data showed how specific virus strains were transmitted across geographic areas.

Chretien et al. argue that mathematical modeling efforts could be more useful in future pubic health emergencies if modelers cooperated more, and suggest the collaborative approach of weather forecasters as a good example to follow. Greater data sharing and the creation of standards for epidemic modeling would aid better collaboration.

https://doi.org/10.7554/eLife.09186.002

Introduction

On March 23, 2014, the Ministry of Health Guinea notified the World Health Organization (WHO) of a rapidly evolving outbreak of Ebola virus disease (EVD), now believed to have begun in December 2013. The epidemic spread through West Africa and reached Europe and the United States. As of November 4, 2015, WHO reported more than 28,000 cumulative cases and 11,000 deaths in Guinea, Liberia, and Sierra Leone, where transmission had been most intense (World Health Organization, 2016).

As the emergency progressed, researchers developed mathematical models of the epidemiological dynamics. Modelers have assessed ongoing epidemics previously, but the prominence of recent EVD work, enabled by existing research programs for infectious disease modeling (National Institutes of Health, 2016a; National Institutes of Health, 2016b) and online availability of EVD data via WHO (World Health Organization, 2016), Ministries of Health of affected countries, or modelers who transcribed and organized public WHO or Ministry of Health data (Rivers C) may be unprecedented. The efforts for this outbreak have been numerous and diverse, with major media incorporating modeling results in many pieces throughout the outbreak. U.S. Government decision making has benefited from modeling results at key moments during the response (Robinson R).

We draw on this vigorous response of the epidemiological modeling community to the EVD epidemic to review (Moher et al., 2009) the application of modeling to public health emergencies, and identify lessons to guide the modeling response to future emergencies.

Results

Overview of modeling applications

We identified 66 publications meeting inclusion criteria (Figure 1).

Figure 1
Download asset Open asset
Literature search flow.
https://doi.org/10.7554/eLife.09186.003

Models addressed 6 key uncertainties about the EVD epidemic: transmissibility, typically represented by the reproduction number (R, the average number of people each infected person infects; assessed in 41 publications); effectiveness of various interventions that had been or might be implemented (in 29 publications); epidemic forecast (in 29 publications); regional or international spreading patterns or risk (in 15 publications); phylogenetics of EVD viruses (in 9 publications); and feasibility of conducting vaccine trials in West Africa (in 2 publications) (Table 1, Supplementary file 1).

Table 1

Overview of modeling publications on the 2013-present EVD epidemic.

https://doi.org/10.7554/eLife.09186.004
Ref.Date of latest EVD dataDate publishedEVD data was pre-existing and publicUncertainties addressed
RInterventionsForecastSpreadPhylogeneticsClinical trials
Baize et al., 2014 3/20/144/16/14No*
Dudas and Rambaut, 2014 3/20/145/2/14Yes*
Alizon et al., 2014 6/18/1412/13/14Yes**
Gire et al., 2014 6/18/148/28/14No**
Stadler et al., 2014 6/18/1410/6/14Yes*
Volz and Pond, 2014 6/18/1410/24/14Yes*
Pandey et al., 2014 8/7/1410/30/14Yes***
Gomes et al., 2014 8/9/149/2/14Yes***
Valdez et al., 2015 8/15/147/20/15Yes****
Merler et al., 2015 8/16/141/7/15Yes****
Rainisch et al., 2015 8/16/142/18/15Yes*
Althaus, 2014 8/20/149/2/14Yes*
Fisman et al., 2014 8/22/149/8/14Yes**
Nishiura and Chowell, 2014 8/26/149/11/14Yes**
Poletto et al., 2014 8/27/1410/23/14Yes**
Meltzer et al., 2014 8/28/149/26/14Yes***
Agusto et al., 2015 8/29/144/23/15Yes**
Althaus, 2015 8/31/144/19/15Yes*
Scarpino et al., 2014 8/31/1412/15/14Yes*
Weitz and Dushoff, 2015 8/31/143/4/15Yes**
Drake et al., 2015 9/2/1410/30/14Yes***
Towers et al., 2014 9/8/149/18/14Yes**
Bellan et al., 2014 9/14/1410/14/14Yes*
Chowell et al., 2015 9/14/141/19/15Yes*
Cooper et al., 2015 9/14/144/14/15Yes*
Read et al., 2015 9/14/1411/12/14Yes**
WHO Ebola Response Team, 2014 9/14/149/23/14No***
Faye et al., 2015 9/16/141/23/15No**
Bogoch et al., 2015 9/21/1410/21/14Yes**
Yamin et al., 2014 9/22/1410/28/14No**
Lewnard et al., 2014 9/23/1410/24/14Yes***
Webb et al., 2015 9/23/141/30/15Yes***
Shaman et al., 2014 9/28/1410/27/14Yes**
Chowell et al., 2014 10/1/1411/20/14Yes**
Fasina et al., 2014 10/1/1410/9/14Yes*
Khan et al., 2015 10/1/142/24/15Yes*
Rivers et al., 2014 10/5/1410/16/14Yes***
Xia et al., 2015 10/7/149/8/15Yes**
Majumder et al., 2014 10/11/144/28/15Yes**
Kiskowski, 2014 10/15/1411/13/14Yes**
Fisman and Tuite, 2014 10/18/1411/21/14Yes***
Althaus et al., 2015 10/20/141/15/15Yes***
Simon-Loriere et al., 2015 10/25/146/24/15No*
Rainisch et al., 2015 10/31/146/16/15Yes*
Fast et al., 2015 11/1/145/15/15Yes*
Kucharski et al., 2015 11/1/142/18/15Yes***
Tong et al., 2015 11/11/145/13/15No**
Hoenen et al., 2015 11/21/143/26/15No*
Cope et al., 2014 12/3/1412/10/14Yes**
White et al., 2014 12/3/141/30/15Yes***
WHO Ebola Response Team, 2015 12/14/1412/24/14No**
Chowell et al., 2014 12/17/141/21/15Yes*
Siettos et al., 2014 12/21/143/9/15Yes**
Park et al., 2015 12/26/146/18/15No*
Nadhem and Nejib, 2015 12/30/146/14/15Yes*
Camacho et al., 2015 1/18/152/10/15Yes**
Carroll et al., 2015 1/31/156/17/15No**
Bellan et al., 2015 2/9/154/15/15Yes**
Barbarossa et al., 2015 2/13/157/21/15Yes***
Kugelman et al., 2015 2/14/156/12/15No*
Cleaton et al., 2015 2/28/159/3/15Yes*
Wang and Zhong, 2015 3/18/153/24/15Yes*
Toth et al., 2015 3/31/157/14/15Yes**
Dong et al., 2015 4/3/159/5/15Yes**
Browne et al., 2015 4/12/155/14/15Yes**
Zinszer et al., 2015 5/13/159/1/15Yes*

The number of publications with models to estimate R increased rapidly early in the epidemic, along with those including intervention, forecasting, and regional and international spread models; the growth rate of publications with phylogenetic modeling applications and clinical trial models increased later in the epidemic (Figure 2).

Figure 2
Download asset Open asset
Cumulative number of modeling applications by date of most recent EVD data used.

The figure includes 125 modeling applications across the 66 publications.

https://doi.org/10.7554/eLife.09186.005

Of the 125 models reported across the studies, 74% included mechanistic assumptions about disease transmission (e.g., compartmental, agent-based, or phylogenetic models), while 26% were purely phenomenological (Supplementary file 2).

Data sources

For 54 (82%) of the 66 publications, the only EVD data used was pre-existing and publicly-available (Table 1). Typically, these were aggregate case data posted online by the WHO or affected countries, or Ebola virus genetic data released previously during the epidemic. Twelve studies used original EVD epidemiological data (Baize et al., 2014; WHO Ebola Response Team, 2014; 2015; Faye et al., 2015; Yamin et al., 2014) or genomic data (Baize et al., 2014; Gire et al., 2014; Simon-Loriere et al., 2015; Tong et al., 2015; Hoenen et al., 2015; Park et al., 2015; Carroll et al., 2015; Kugelman et al., 2015).

Examples of additional data used for some modeling applications include official reports of social mobilization efforts (Fast et al., 2015), media reports of case clusters (Cleaton et al., 2015), media reports of events that may curtail or aggravate transmission (Majumder et al., 2014), and international air travel data (Gomes et al., 2014; Poletto et al., 2014; Read et al., 2015; Bogoch et al., 2015; Rainisch et al., 2015; Cope et al., 2014). Several studies incorporated spatial data on EVD cases into models of regional EVD spread (Gire et al., 2014; Merler et al., 2015; Rainisch et al., 2015; Tong et al., 2015; Carroll et al., 2015; Zinszer et al., 2015).

Data and results sharing

Of the 12 studies that collected original EVD data, 9 released those data before or at the time of publication (8 with Ebola virus genetic data deposited in GenBank (Baize et al., 2014; Gire et al., 2014; Simon-Loriere et al., 2015; Tong et al., 2015; Hoenen et al., 2015; Park et al., 2015; Carroll et al., 2015; Kugelman et al., 2015) and 1 with detailed epidemiological data in the online publication (Yamin et al., 2014). Many publications used results from the WHO Ebola Response Team investigations (WHO Ebola Response Team, 2014; 2015) (for example, estimates of the generation time, case fatality rate, or other epidemiological parameters as model inputs), but the detailed epidemiological data from these studies, to date, are not publicly available.

Accumulation of shared EVD data over successive studies was evident especially in the phylogenetic analyses. For example, all phylogenetic studies published after release of the initial Ebola virus sequences by (Baize et al., 2014) (Guinea) and (Gire et al., 2014) (Sierra Leone) incorporated those sequence data.

Across all studies, the publication lag (defined as date of most recent EVD data used to date of online publication) was almost 3 months (median [interquartile range] = 85 [30–157] days). The lag varied across modeling applications, and was considerably shorter in studies that included models to estimate R (median = 58 days for publications with R estimation versus 118 days for others) or to forecast (median = 50 versus 125 days) (Figure 3).

Figure 3
Download asset Open asset
Publication lag by type of modeling application.

The vertical red and turquoise lines indicate the median lag for publications including and not including, respectively, the type of modeling application.

https://doi.org/10.7554/eLife.09186.006

Lags were longest for studies with phylogenetic and clinical trials applications (median = 125 and 108 days, respectively), although there were fewer publications with these models.

Modeling results: R and forecasts

Forty-one publications characterized epidemic dynamics using epidemiological (N=36), genomic (N=4), or news report data (N=1). Twenty-four of these provided estimates of the basic reproduction number (R0) for Guinea, Liberia, Sierra Leone, or West Africa, using epidemiological or genomic data (Figure 4, Supplementary file 3).

Figure 4
Download asset Open asset
R0 estimates by type of model input data.

Aggregate, case counts released by the WHO or Ministries of Health; Line-level, individual-level data from epidemiological investigations; Genomic, Ebola virus sequence data. The Figure excludes an outlier estimate of 8.33 for Sierra Leone (Fisman et al., 2014).

https://doi.org/10.7554/eLife.09186.007

There were 16 country-specific estimates of R0 for Guinea, Liberia, or Sierra Leone that used EVD epidemiological data (aggregate or line-level) and provided 95% confidence or credible intervals (CIs). Median CI width was about 85% smaller for models that used cumulative EVD counts (N=11 models in 5 publications) than for models that used disaggregated EVD case data, such as weekly counts (N=5 models in 3 publications) (Figure 5).

Figure 5
Download asset Open asset
R0 estimates and CIs by type of epidemiological input data.

Disaggregated data typically were weekly counts. Top row: Vertical lines indicate 95% CIs. Bottom row: Horizontal bars indicate median CI width.

https://doi.org/10.7554/eLife.09186.008

Although CIs were also narrower for models when deterministic rather than stochastic methods were used to estimate parameter uncertainty, all of the deterministic results came from a single study (Figure 6).

Figure 6
Download asset Open asset
R0 estimates and CIs by model fitting method.

Top row: Vertical lines indicate 95% CIs. Bottom row: Horizontal bars indicate median CI width.

https://doi.org/10.7554/eLife.09186.009

Fifteen publications provided numerical forecasts of cumulative EVD incidence for West African countries. Of 22 models that assumed no additional response measures beyond those implemented at the time (i.e., 'status quo' assumptions), 18 overestimated the future number of cases (Figure 7, Supplementary file 4).

Figure 7
Download asset Open asset
Accuracy of cumulative incidence forecasts.

Accuracy is shown as the ratio of predicted incidence to incidence subsequently reported by the WHO. 'Dampening' refers to various approaches to restrict the growth of forecasted incidence over time. Top row: Accuracy by date of forecast. Bottom row: Accuracy by forecast lead time ('Horizon'). The Figure excludes one forecast with horizon > 1 year (Fisman and Tuite, 2014).

https://doi.org/10.7554/eLife.09186.010

In multivariate analysis, forecast error was lower for forecasts made later in the outbreak (14% reduction in mean absolute percentage error [MAPE] per week, P<0.001), higher for forecasts with longer time horizons (29% increase in MAPE per week, P<0.01), and lower for forecasts that used decay terms, spatially heterogeneous contact patterns, or other methods that served to constrain projected incidence growth (90% reduction in MAPE, P<0.01). Country and number of parameters in the model were not statistically significant predictors of forecast accuracy.

Discussion

We identified 66 modeling publications during approximately 18 months of the EVD response that assessed trends in the intensity of transmission, effectiveness of control measures, future case counts, regional and international spreading risk, Ebola virus phylogenetic relationships and recent evolutionary dynamics, and feasibility of clinical trials in West Africa. We found a heavy dependence on public data for EVD modeling, and identified factors that might have influenced model performance. To our knowledge, this review is one of the most comprehensive assessments of mathematical modeling applied to a single real-world public health emergency.

An important caveat of our review is that it only captures published results. We are aware of additional EVD epidemiological investigations and modeling not yet published. Some modelers providing direct support to operational response efforts have not published results, possibly because of operational demands.

Also, we could not account comprehensively for the sources of variation across studies. For example, studies that estimated R0 using the same data sources at about the same time reported varied results. Such variation may, in part, reflect the problem of identifiability, with different R0 estimates possible for models that perform equally well depending on other parameter values (Weitz and Dushoff, 2015). Ideally, an investigation into this heterogeneity would include implementation of models in a common testing environment.

Our review suggests several possible steps for improving the application of epidemiological modeling during public health emergencies. First, agreement on community best practices could improve the quality of modeling support to decision-makers. For example, our analysis is consistent with simulation studies showing underestimation of uncertainty in estimating R0 with cumulative (as opposed to disaggregated) incidence data, and supports the recommendation to use disaggregated data and stochastic models (King et al., 2015). Additionally, incidence forecasts provided reasonable prospective estimates several weeks forward in time during the initial phase; however, given available data and methodologies these forecasts became progressively more inaccurate as they projected dynamics beyond several weeks. Validation of incidence forecasts against other relevant data, such as hospital admissions and contacts identified, also could provide evidence that the assumptions are sound.

The 2014 onwards ebola outbreak in West Africa clearly highlights the need for a better understanding of how increasing awareness of severe infections within a community decreases their transmissibility even in the absence of specific interventions. Advancing methodological approaches to capture this effect, such as dampening approaches, might help account for behavioral changes, interventions, contact heterogeneity, or other factors that can be expected in a public health emergency which likely will improve forecasting accuracy. Establishing best practices within the community will allow decision-makers the ability to more quickly accept methodologies and results that have been generated via these best practices. Hence, decisions based on these results can happen more quickly.

Second, modeling coordination could facilitate direct comparison of modeling results, identifying issues on which diverse approaches agree and areas of greater uncertainty. Epidemiological modelers might learn from comparison initiatives in modeling of influenza (Centers for Disease Control and Prevention, 2013), dengue (US Department of Commerce), and HIV (HIV modeling consortium); and in other fields such as climate forecasting Intergovernmental Panel on Climate Change, 2010). For epidemiological application, an ensemble approach should preserve methodological diversity to exploit the full range of state-of-the-art modeling methods, but include enough standardization to enable cross-model comparison. Establishing an initial architecture for a coordinated, ensemble effort now could assist the response to EVD, and future public health emergencies.

Perhaps most importantly, outbreak modeling efforts would be much more fruitful if data and analytical results could be made available more quickly to all interested parties (Yozwiak et al., 2015). The publication timelines for academic journals typically will not be consistent with decision-making needs during public health emergencies like the EVD epidemic, where the epidemiological situation was highly dynamic and the usefulness of data and forecasts time-constrained. Establishing mechanisms for modelers without special access to the official epidemiological teams to share interim results would expand the evidence base for response decision-making. Ideally, data should be made available online in machine-readable form to facilitate use in analyses. Modelers and other analysts expended enormous effort during the EVD epidemic transcribing data posted online in pdf documents.

New norms for data-sharing during public health emergencies (World Health Organization, 2015) would remove the most obvious hurdle for model comparison. The current situation where groups either negotiate bilaterally with individual countries or work exclusively with global health and development agencies is understandable, but highly ineffective. The EVD outbreak highlights again – after the 2003 Severe Acute Respiratory Syndrome epidemic and 2009 influenza A (H1N1) pandemic – that an independent, well-resourced global data observatory could greatly facilitate the public health response in many ways, not least of which would be the enablement of rapid, high quality, and easily comparable disease-dynamic studies.

Materials and methods

For this review, we adapted the PRISMA methodology (Moher et al., 2009) to identify quantitative modeling studies of the 2013-present West Africa EVD epidemic. We searched PubMed on September 24, 2015, for publications in English since December 1, 2013, using the term ‘Ebola’ in any field. We reviewed all returned abstracts and selected ones for confirmatory, full-text review that mentioned use of quantitative models to characterize or predict epidemic dynamics or evaluate interventions. We included studies that met this criterion in full-text review.

We excluded studies of clinical prediction models, viral or physiological function models, ecological niche models, animal reservoir models, and publications that did not use data from the 2013-present West Africa EVD epidemic.

For included publications, we recorded the geographic settings, date of most recent EVD data used and date of publication, type of EVD data used, questions the models addressed, modeling approaches, and key results, including estimates of the basic reproduction number (R0) and forecasts of future EVD incidence provided in the main text of the publications. To assess forecast accuracy, we compared predictions of models made under ‘status quo’ assumptions (i.e., without explicit inclusion of additional interventions or behavioral changes) to EVD incidence data subsequently released by the WHO (World Health Organization, 2016), using the WHO figures dated soonest after the forecast target date.

References

    1. Carroll MW
    2. Matthews DA
    3. Hiscox JA
    4. Elmore MJ
    5. Pollakis G
    6. Rambaut A
    7. Hewson R
    8. García-Dorival I
    9. Bore JA
    10. Koundouno R
    11. Abdellati S
    12. Afrough B
    13. Aiyepada J
    14. Akhilomen P
    15. Asogun D
    16. Atkinson B
    17. Badusche M
    18. Bah A
    19. Bate S
    20. Baumann J
    21. Becker D
    22. Becker-Ziaja B
    23. Bocquin A
    24. Borremans B
    25. Bosworth A
    26. Boettcher JP
    27. Cannas A
    28. Carletti F
    29. Castilletti C
    30. Clark S
    31. Colavita F
    32. Diederich S
    33. Donatus A
    34. Duraffour S
    35. Ehichioya D
    36. Ellerbrok H
    37. Fernandez-Garcia MD
    38. Fizet A
    39. Fleischmann E
    40. Gryseels S
    41. Hermelink A
    42. Hinzmann J
    43. Hopf-Guevara U
    44. Ighodalo Y
    45. Jameson L
    46. Kelterbaum A
    47. Kis Z
    48. Kloth S
    49. Kohl C
    50. Korva M
    51. Kraus A
    52. Kuisma E
    53. Kurth A
    54. Liedigk B
    55. Logue CH
    56. Lüdtke A
    57. Maes P
    58. McCowen J
    59. Mély S
    60. Mertens M
    61. Meschi S
    62. Meyer B
    63. Michel J
    64. Molkenthin P
    65. Muñoz-Fontela C
    66. Muth D
    67. Newman EN
    68. Ngabo D
    69. Oestereich L
    70. Okosun J
    71. Olokor T
    72. Omiunu R
    73. Omomoh E
    74. Pallasch E
    75. Pályi B
    76. Portmann J
    77. Pottage T
    78. Pratt C
    79. Priesnitz S
    80. Quartu S
    81. Rappe J
    82. Repits J
    83. Richter M
    84. Rudolf M
    85. Sachse A
    86. Schmidt KM
    87. Schudt G
    88. Strecker T
    89. Thom R
    90. Thomas S
    91. Tobin E
    92. Tolley H
    93. Trautner J
    94. Vermoesen T
    95. Vitoriano I
    96. Wagner M
    97. Wolff S
    98. Yue C
    99. Capobianchi MR
    100. Kretschmer B
    101. Hall Y
    102. Kenny JG
    103. Rickett NY
    104. Dudas G
    105. Coltart CE
    106. Kerber R
    107. Steer D
    108. Wright C
    109. Senyah F
    110. Keita S
    111. Drury P
    112. Diallo B
    113. de Clerck H
    114. Van Herp M
    115. Sprecher A
    116. Traore A
    117. Diakite M
    118. Konde MK
    119. Koivogui L
    120. Magassouba N
    121. Avšič-Županc T
    122. Nitsche A
    123. Strasser M
    124. Ippolito G
    125. Becker S
    126. Stoecker K
    127. Gabriel M
    128. Raoul H
    129. Di Caro A
    130. Wölfel R
    131. Formenty P
    132. Günther S
    (2015) Temporal and spatial analysis of the 2014–2015 ebola virus outbreak in west africa
    Nature 524:97–101.
    https://doi.org/10.1038/nature14594
    1. Meltzer MI
    2. Atkins CY
    3. Santibanez S
    4. Knust B
    5. Petersen BW
    6. Ervin ED
    7. Nichol ST
    8. Damon IK
    9. Washington ML
    (2014)
    Estimating the future number of cases in the ebola epidemic--liberia and sierra leone, 2014-2015
    Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002) 63 Suppl 3:1–14.
    1. Nishiura H
    2. Chowell G
    (2014) Early transmission dynamics of ebola virus disease (eVD), West Africa, march to august 2014
    Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 19:20894.
    https://doi.org/10.2807/1560-7917.ES2014.19.36.20894

Article and author information

Author details

  1. Jean-Paul Chretien

    Department of Defense, Division of Integrated Biosurveillance, Armed Forces Health Surveillance Center, Silver Spring, United States
    Contribution
    J-PC, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    For correspondence
    JPChretien@gmail.com
    Competing interests
    The authors declare that no competing interests exist.

  2. Steven Riley

    MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom
    Contribution
    SR, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Competing interests
    The authors declare that no competing interests exist.

  3. Dylan B George

    Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Washington, United States
    Contribution
    DBG, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Competing interests
    The authors declare that no competing interests exist.

Funding

No external funding was received for this work.

Acknowledgements

We thank the reviewers for excellent comments that improved the manuscript. The views expressed are those of the authors and do not necessarily reflect the views of any part of the US Government.

Version history

  1. Received: June 2, 2015
  2. Accepted: November 19, 2015
  3. Accepted Manuscript published: December 8, 2015 (version 1)
  4. Version of Record published: February 16, 2016 (version 2)

Copyright

© 2015, Chretien et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,262
    Page views
  • 1,030
    Downloads
  • 99
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jean-Paul Chretien
  2. Steven Riley
  3. Dylan B George
(2015)
Mathematical modeling of the West Africa Ebola epidemic
eLife 4:e09186.
https://doi.org/10.7554/eLife.09186

Share this article

https://doi.org/10.7554/eLife.09186

Categories and tags

Research organism

Further reading

    1. Epidemiology and Global Health

    A retrospective cohort study of Paxlovid efficacy depending on treatment time in hospitalized COVID-19 patients

    Zhanwei Du, Lin Wang ... Lauren A Meyers
    Short Report

    Paxlovid, a SARS-CoV-2 antiviral, not only prevents severe illness but also curtails viral shedding, lowering transmission risks from treated patients. By fitting a mathematical model of within-host Omicron viral dynamics to electronic health records data from 208 hospitalized patients in Hong Kong, we estimate that Paxlovid can inhibit over 90% of viral replication. However, its effectiveness critically depends on the timing of treatment. If treatment is initiated three days after symptoms first appear, we estimate a 17% chance of a post-treatment viral rebound and a 12% (95% CI: 0%-16%) reduction in overall infectiousness for non-rebound cases. Earlier treatment significantly elevates the risk of rebound without further reducing infectiousness, whereas starting beyond five days reduces its efficacy in curbing peak viral shedding. Among the 104 patients who received Paxlovid, 62% began treatment within an optimal three-to-five-day day window after symptoms appeared. Our findings indicate that broader global access to Paxlovid, coupled with appropriately timed treatment, can mitigate the severity and transmission of SARS-Cov-2.

    1. Epidemiology and Global Health

    Higher ratio of plasma omega-6/omega-3 fatty acids is associated with greater risk of all-cause, cancer, and cardiovascular mortality: A population-based cohort study in UK Biobank

    Yuchen Zhang, Yitang Sun ... Kaixiong Ye
    Research Article

    Background:

    Circulating omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) have been associated with various chronic diseases and mortality, but results are conflicting. Few studies examined the role of omega-6/omega-3 ratio in mortality.

    Methods:

    We investigated plasma omega-3 and omega-6 PUFAs and their ratio in relation to all-cause and cause-specific mortality in a large prospective cohort, the UK Biobank. Of 85,425 participants who had complete information on circulating PUFAs, 6461 died during follow-up, including 2794 from cancer and 1668 from cardiovascular disease (CVD). Associations were estimated by multivariable Cox proportional hazards regression with adjustment for relevant risk factors.

    Results:

    Risk for all three mortality outcomes increased as the ratio of omega-6/omega-3 PUFAs increased (all Ptrend <0.05). Comparing the highest to the lowest quintiles, individuals had 26% (95% CI, 15–38%) higher total mortality, 14% (95% CI, 0–31%) higher cancer mortality, and 31% (95% CI, 10–55%) higher CVD mortality. Moreover, omega-3 and omega-6 PUFAs in plasma were all inversely associated with all-cause, cancer, and CVD mortality, with omega-3 showing stronger effects.

    Conclusions:

    Using a population-based cohort in UK Biobank, our study revealed a strong association between the ratio of circulating omega-6/omega-3 PUFAs and the risk of all-cause, cancer, and CVD mortality.

    Funding:

    Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institute of Health under the award number R35GM143060 (KY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

    1. Ecology
    2. Epidemiology and Global Health

    Exploring factors shaping antibiotic resistance patterns in Streptococcus pneumoniae during the 2020 COVID-19 pandemic

    Aleksandra Kovacevic, David RM Smith ... Lulla Opatowski
    Research Article

    Non-pharmaceutical interventions implemented to block SARS-CoV-2 transmission in early 2020 led to global reductions in the incidence of invasive pneumococcal disease (IPD). By contrast, most European countries reported an increase in antibiotic resistance among invasive Streptococcus pneumoniae isolates from 2019 to 2020, while an increasing number of studies reported stable pneumococcal carriage prevalence over the same period. To disentangle the impacts of the COVID-19 pandemic on pneumococcal epidemiology in the community setting, we propose a mathematical model formalizing simultaneous transmission of SARS-CoV-2 and antibiotic-sensitive and -resistant strains of S. pneumoniae. To test hypotheses underlying these trends five mechanisms were built into the model and examined: (1) a population-wide reduction of antibiotic prescriptions in the community, (2) lockdown effect on pneumococcal transmission, (3) a reduced risk of developing an IPD due to the absence of common respiratory viruses, (4) community azithromycin use in COVID-19 infected individuals, (5) and a longer carriage duration of antibiotic-resistant pneumococcal strains. Among 31 possible pandemic scenarios involving mechanisms individually or in combination, model simulations surprisingly identified only two scenarios that reproduced the reported trends in the general population. They included factors (1), (3), and (4). These scenarios replicated a nearly 50% reduction in annual IPD, and an increase in antibiotic resistance from 20% to 22%, all while maintaining a relatively stable pneumococcal carriage. Exploring further, higher SARS-CoV-2 R0 values and synergistic within-host virus-bacteria interaction mechanisms could have additionally contributed to the observed antibiotic resistance increase. Our work demonstrates the utility of the mathematical modeling approach in unraveling the complex effects of the COVID-19 pandemic responses on AMR dynamics.